Oncology/Hematology Market Research Reports & Industry Analysis
Oncology/Hematology Industry Research & Market Reports
-
Real-world Data (RWD) by Source (EMR, Claims, Pharmacy, Disease Registries), Application [Market Access, Drug Development & Approvals (Oncology, Neurology), Post Market Surveillance], and End User (Pharma, Payers, Providers) - Global Forecast to 2029
... (RWD) by Source (EMR, Claims, Pharmacy, Disease Registries), Application [Market Access, Drug Development & Approvals (Oncology, Neurology), Post Market Surveillance], and End User (Pharma, Payers, Providers) - Global Forecast to 2029 The real-world data (RWD) ... Read More
-
Therapeutics Enzymes Market Forecasts to 2028 – Global Analysis By Product Type (Chitinase, Asparginase and Other Product Types), By Application (Leukemia, Stomach Disorders and Other Applications), By End User (Drug manufacturers, Hospitals, Private clinics and Research laboratories) and Geography
... Research laboratories) and Geography According to Stratistics MRC, the Global Therapeutic Enzymes Market is accounted for $8467.9 million in 2022 and is expected to reach $18684.8 million by 2028 growing at a CAGR of 14.1% ... Read More
-
The Value of a Modern Data Infrastructure to Accelerate Clinical Diagnosis: The Case of Munich Leukemia Laboratory
... its increasing compute and storage needs as well as support its business innovation plans. The case analyzes key factors that helped MLL to successfully analyze and process next-generation sequencing (NGS) and other diagnostic data in ... Read More
-
Minimal Residual Disease Testing Market by Technology (PCR, Flow Cytometry, NGS), Application (Leukemia, Lymphoma, Solid Tumors), End User(Hospitals, Specialty Clinics, Diagnostic Labs, Research and Academic Institutes) & Region - Global Forecast to 2027
... minimal residual disease testing market is valued at an estimated USD 1.2 Billion in 2022 and is projected to reach USD 2.3 Billion by 2027, at a CAGR of 14.0% during the forecast period. Market ... Read More
-
Extensive Stage Small Cell Lung Cancer Market - A Global and Regional Analysis: Focus on Epidemiology, Product, and Region - Analysis and Forecast, 2022-2032
... small cell lung cancer is extremely aggressive sub-type of small cell lung cancer. Small cell lung itself is a sub-type of lung cancer which accounts for less than 20% cases. The treatment of extensive stage ... Read More
-
The World Market for Liquid Biopsy, 2023
... Market now and in 2027. The report can be useful for business planning, market share assessment, competitive research, and due diligence for mergers and acquisitions and other partnerships. Liquid biopsy is gaining acceptance each year. ... Read More
-
Saudi Arabia Nuclear Imaging Equipment Market, By Type (PET Imaging Systems, Gamma Camera Imaging Systems), By Application (Oncology, Cardiology, Neurology, Others), By End User (Hospitals & Clinics, Diagnostic Imaging Centers, Others), By Region, Competi
... & Opportunities, 2027 Saudi Arabia nuclear imaging equipment market is anticipated to register growth with an impressive CAGR in the forecast period, 2023-2027, on the account of increasing demands for the early diagnosis of the ... Read More
-
Global Castrate Resistant Prostate Cancer Therapeutics Market Insights, Forecast to 2028
... Therapeutics estimated at US$ 15,175.51 million in the year 2022, is projected to reach a revised size of US$ 28,717.44 million by 2028, growing at a CAGR of 11.22% during the forecast period 2022-2028. The ... Read More
-
Europe Microwave Ablation Market Size, Share & Industry Trends Analysis Report By End-user, By Component (Accessories, Generator, and Power Distribution System), By Application (Oncology, Cardiology, Urology, Orthopedic), By Country and Growth Forecast, 2022 - 2028
... The Europe Microwave Ablation Market would witness market growth of 13.6% CAGR during the forecast period (2022-2028). Microwave ablation technology is expected to gain profitable revenue share in the near future. The use of microwave ... Read More
-
Digital Marketing Trends in Breast Cancer
... followed by Eli Lilly’s Verzenio.com (4.4 million visits). The highest proportion of traffic to branded sites originated from direct sources, followed by organic sources. Pfizer spent the most on digital display advertising (DDA) for Ibrance.com ... Read More
-
Bile Duct Cancer (Cholangiocarcinoma) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... will be more than 71,000 diagnosed prevalent cases of bile duct cancer across 16 pharmaceutical markets. There are seven marketed innovator drugs for the treatment of bile duct cancer, mostly tyrosine kinase inhibitors. R&D activity ... Read More
-
Melanoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... overview of the Melanoma (Oncology) pipeline landscape. Melanoma is a tumor that develops as a result of the malignant transformation of melanocytes. These cells are derived from the neural crest. Melanomas usually occur on the ... Read More
-
Small-Cell Lung Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Development, 2022, provides an overview of the Small-Cell Lung Cancer (Oncology) pipeline landscape. Small cell lung cancer (SCLC) is a fast-growing type of lung cancer. It spreads much more quickly than non-small cell lung cancer. ... Read More
-
Bladder Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Bladder Cancer (Oncology) pipeline landscape. Bladder cancer occurs in tissues of the urinary bladder. Symptoms include blood or blood clots in the urine, frequent urination, lower back pain on one ... Read More
-
Microsurgery Market Size, Share & Trends Analysis Report By Equipment (Operating Microscopes, Micro Sutures), By Application (Neurology, Oncology), By Procedure, By End-use, And Segment Forecasts, 2023 - 2030
... microsurgery market size is expected to reach USD 3.3 billion by 2030, registering a CAGR of 5.5% during the forecast period, according to a new report by Grand View Research, Inc. The industry growth is ... Read More
-
Molecular Oncology Diagnostics Market - A Global and Regional Analysis: Focus on Product, Technology, Application, Cancer Type, End User, and Region - Analysis and Forecast, 2022-2032
... molecular oncology diagnostics market was valued at $3,620.6 million in 2021 and is anticipated to reach $12,130.5 million by 2032, witnessing a CAGR of 11.43% during the forecast period 2022-2032. The growth in the global ... Read More
-
Immuno-oncology Drugs Market, by Treatment Type (Immune Checkpoint Inhibitors (PD-1, PD-L1, CTLA-4), Immune System Modulators, Cancer Vaccines, Oncolytic Virus, Others), by Disease Type (Melanoma, Lung Cancer, Blood Cancer, Renal Cell Carcinoma, Prostate Cancer, Bladder Cancer, Others (Breast Cancer, Thyroid Cancer, etc.)), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Others (Breast Cancer, Thyroid Cancer, etc.)), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, ... Read More
-
Home Healthcare Market by Product (Dialysis Equipment, IV Equipment, Ventilators, Coagulation Monitors, Peak Flow Meters), Service (Infusion Therapy, Skilled Nursing, Hospice), Indication (Cancer, Wound Care, Diabetes), and Region - Global Forecast to 202
... home healthcare market is projected to reach USD 340.2 Billion by 2027 from USD 226.0 Billion in 2022, at a CAGR of 8.5% during the forecast period Growth in this market is mainly driven by ... Read More
-
North America Embolotherapy Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Embolic Agent and Support Device), Disease Indication (Cancer, Peripheral Vascular Disease, Neurological Disease, Urological and Nephrological Disorder, Gastrointestinal Disorder, and Other), Procedure [Transcatheter Arterial Embolization (TAE), Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT), and Transarterial Chemoembolization (TACE)], and End User (Hospital & Clinic, Ambulatory Surgery Center, and Other End User)
... and Other), Procedure [Transcatheter Arterial Embolization (TAE), Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT), and Transarterial Chemoembolization (TACE)], and End User (Hospital & Clinic, Ambulatory Surgery Center, and Other End User) The embolotherapy market ... Read More
-
Hemato Oncology Testing Market by Product & Services (Services, Assay Kits), Cancer (Leukemia (Acute Myeloid, Acute Lymphocytic), Lymphoma (Non-Hodgkin, Hodgkin), Technology (PCR, NGS), End User - Global Forecast to 2027
... market is projected to reach USD 5.6 billion by 2027 from an estimated USD 2.9 Billion in 2022, at a CAGR of 14.2%. The growth in this market is attributed to the growing incidence of ... Read More
-
Asia Pacific Embolotherapy Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Embolic Agent and Support Device), Disease Indication (Cancer, Peripheral Vascular Disease, Neurological Disease, Urological and Nephrological Disorder, Gastrointestinal Disorder, and Other), Procedure [Transcatheter Arterial Embolization (TAE), Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT), and Transarterial Chemoembolization (TACE)], and End User (Hospital & Clinic, Ambulatory Surgery Center, and Other End User)
... and Other), Procedure [Transcatheter Arterial Embolization (TAE), Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT), and Transarterial Chemoembolization (TACE)], and End User (Hospital & Clinic, Ambulatory Surgery Center, and Other End User) The embolotherapy market ... Read More
-
Europe Embolotherapy Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Embolic Agent and Support Device), Disease Indication (Cancer, Peripheral Vascular Disease, Neurological Disease, Urological and Nephrological Disorder, Gastrointestinal Disorder, and Other), Procedure [Transcatheter Arterial Embolization (TAE), Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT), and Transarterial Chemoembolization (TACE)], and End User (Hospital & Clinic, Ambulatory Surgery Center, and Other End User)
... Other), Procedure [Transcatheter Arterial Embolization (TAE), Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT), and Transarterial Chemoembolization (TACE)], and End User (Hospital & Clinic, Ambulatory Surgery Center, and Other End User) The embolotherapy market in ... Read More
-
NAMPT Inhibitors Pipeline Analysis (Phase: Phase II, Phase I/II, Phase I, and Preclinical; and Type of Molecule: Small Molecules and Biologics) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
... Analysis Market – Scope of Report TMR’s report on the global NAMPT inhibitors pipeline analysis market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators ... Read More
-
Bladder Cancer Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Bladder Cancer Clinical trials scenario. This report provides top line data relating to the clinical trials on ... Read More
-
Global Diffuse Large B-cell Lymphoma Therapeutics Market - 2022-2029
... by 2028, growing at a CAGR of 7.50 % during the forecast period (2022-2029). Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma (NHL). DLBCL is an aggressive (fast-growing) NHL that ... Read More
Research Assistance
